Best Wishes for the Holidays and 2020! |
SHARE ISSUE ON |
|
|
 |
CTN Trial Progress
 Randomizations for Active Studies as of the December 3 trial Progress Report.
CTN-0067 - CHOICES Scale-Up. Enrolled 116
CTN-0069 - OUD in the Emergency Department. Enrolled 689
Total randomizations in active trials: 805
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
Apply for the Learning for Early Careers in Addiction and Diversity (LEAD) Program
Deadline: December 27, 2019
The LEAD Program provides training to early-career research scientists from racial/ethnic minority groups that are underrepresented in the substance use disorder research field.
It uses the NIDA Clinical Trials Network (CTN) as a platform for training investigators via a 3-year program based at the University of California, San Francisco (UCSF).
Visiting scholars spend 3 summers in a 4-week intensive program at UCSF. During the academic year, they work with their primary mentor to collaborate on substance use disorder treatment research conducted in the CTN, develop a professional research network, and conduct a pilot study that will serve as a preliminary study for subsequent NIH funding.
The program provides travel and housing funds for scholars, as well as pilot study funding.
The 2020 summer program will be held from June 29-July 24.
Find out more and apply here.
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
CTN 20th Anniversary Special Issue of Addiction Science & Clinical Practice
 Addiction Science & Clinical Practice is pleased to announce an upcoming special series on the opioid use disorder (OUD) care continuum, specifically articles describing broad research and data supported by the National Drug Abuse Treatment Clinical Trials Network (CTN). The series will commemorate 20 years of CTN research activities.
Edited by E. Jennifer Edelman and Andrew J. Saxon, the series will highlight articles focusing on identification of OUD, access and linkage to care, medication and other treatment initiation, treatment retention, research-practice gaps, and quality of care.
The series will welcome all manuscript submissions on this topic (including study protocols) from CTN-supported researchers and those who work with CTN-supported data. Articles in the series will be made available in open access (free for all) format, supported by the generosity of the NIDA CTN. All submissions to ASCP are subject to editorial and peer review.
CTN policy requires papers to be reviewed in the CTN Publications Committee (PC) prior to being submitted. To participate in the issue, email your manuscript to Jack Blaine and George Bigelow with a copy to Udi Ghitza and Landhing Moran in the Center for the Clinical Trials Network for review and approval.
Submissions will be reviewed on a rolling basis upon receipt and are requested as of 1 February 2020 and no later than 1 July 2020. They should be submitted to the CTN PC at least one month before this deadline.
Find out more here.
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
   
|
Barriers and Facilitators to Recruitment and Enrollment of HIV-Infected Individuals with Opioid Use Disorder in a Clinical Trial
March 23-25, 2020: Annual CTN Steering Committee Meeting